대한약학회 추계총회 및 학술대회 (2009년) vol.2 Targeting Recombinant Adenovirus to Antigen-presenting Cells Via CD40 Significantly Enhances the Therapeutic Effects of an APC-based Anti-tumor Vaccine.

학술대회자료

Targeting Recombinant Adenovirus to Antigen-presenting Cells Via CD40 Significantly Enhances the Therapeutic Effects of an APC-based Anti-tumor Vaccine.

대한약학회
추계총회 및 학술대회
(2009년) vol.2
2009.10

169 - 169 (1 pages)

원문보기

원문저장

Targeting Recombinant Adenovirus to Antigen-presenting Cells Via CD40 Significantly Enhances the Therapeutic Effects of an APC-based Anti-tumor Vaccine.

(0)

(0)

(0)

(0)

Targeting Recombinant Adenovirus to Antigen-presenting Cells Via CD40 Significantly Enhances the Therapeutic Effects of an APC-based Anti-tumor Vaccine.

(0)

(0) 팝업 열기 팝업 닫기

(0)

(0)

(0)